Literature DB >> 10094552

A retrospective anonymous pilot study in screening newborns for HFE mutations in Scandinavian populations.

A T Merryweather-Clarke1, H Simonsen, J D Shearman, J J Pointon, B Nørgaard-Pedersen, K J Robson.   

Abstract

We have retrospectively analyzed 837 random anonymized dried blood spot (DBS) samples from neonatal screening programs in Scandinavia for mutations in HFE, the candidate gene for hemochromatosis. We have found C282Y allele frequencies of 2.3% (+2.0%) (-1.3%) in Greenland, 4.5%+/-1.9% in Iceland, 5.1%+/-2.3% in the Faeroe Islands, and 8.2%+/-2.7% in Denmark. The high prevalence of HFE mutations in Denmark suggests that population screening for the C282Y mutation could be highly advantageous in terms of preventive health care. Long-term follow-up evaluation of C282Y homozygotes and H63D/C282Y compound heterozygotes will give an indication of the penetrance of the mutations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10094552     DOI: 10.1002/(SICI)1098-1004(1999)13:2<154::AID-HUMU8>3.0.CO;2-E

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  12 in total

1.  Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins.

Authors:  J B Whitfield; L M Cullen; E C Jazwinska; L W Powell; A C Heath; G Zhu; D L Duffy; N G Martin
Journal:  Am J Hum Genet       Date:  2000-03-15       Impact factor: 11.025

2.  Reverse cascade screening of newborns for hereditary haemochromatosis: a model for other late onset diseases?

Authors:  E Cadet; D Capron; M Gallet; M-L Omanga-Léké; H Boutignon; C Julier; K J H Robson; J Rochette
Journal:  J Med Genet       Date:  2005-05       Impact factor: 6.318

3.  HFE gene mutation (C282Y) and phenotypic expression among a hospitalised population in a high prevalence area of haemochromatosis.

Authors:  S Distante; J P Berg; K Lande; E Haug; H Bell
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

Review 4.  Population screening for hemochromatosis: has the time finally come?

Authors:  J C Barton; R T Acton
Journal:  Curr Gastroenterol Rep       Date:  2000-02

5.  Frequencies of the hereditary hemochromatosis allele in different populations. Comparison of previous phenotypic methods and novel genotypic methods.

Authors:  Nils Milman; Palle Pedersen; Torkil á Steig; Gitte Vedel Melsen
Journal:  Int J Hematol       Date:  2003-01       Impact factor: 2.490

6.  Storage policies and use of the Danish Newborn Screening Biobank.

Authors:  B Nørgaard-Pedersen; D M Hougaard
Journal:  J Inherit Metab Dis       Date:  2007-07-12       Impact factor: 4.982

7.  Common variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway modulate HFE hemochromatosis penetrance.

Authors:  Jacqueline Milet; Valerie Dehais; Catherine Bourgain; Anne Marie Jouanolle; Annick Mosser; Michele Perrin; Jeff Morcet; Pierre Brissot; Veronique David; Yves Deugnier; Jean Mosser
Journal:  Am J Hum Genet       Date:  2007-08-31       Impact factor: 11.025

8.  Prevalence of 845G>A HFE mutation in Slavic populations: an east-west linear gradient in South Slavs.

Authors:  Grazyna Adler; Jeremy S Clark; Beata Łoniewska; Andrzej Ciechanowicz
Journal:  Croat Med J       Date:  2011-06       Impact factor: 1.351

9.  Association between hemochromatosis genotype and lead exposure among elderly men: the normative aging study.

Authors:  Robert O Wright; Edwin K Silverman; Joel Schwartz; Shring-Wern Tsaih; Jody Senter; David Sparrow; Scott T Weiss; Antonio Aro; Howard Hu
Journal:  Environ Health Perspect       Date:  2004-05       Impact factor: 9.031

10.  Dupuytren's Contracture in Alabama HFE Hemochromatosis Probands.

Authors:  James C Barton; J Clayborn Barton
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2012-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.